{
    "Trade/Device Name(s)": [
        "Premier Resolution System"
    ],
    "Submitter Information": "Trinity Biotech (Primus Corporation, dba Trinity Biotech)",
    "510(k) Number": "K222635",
    "Predicate Device Reference 510(k) Number(s)": [
        "K991127"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GKA"
    ],
    "Summary Letter Date": "August 30, 2022",
    "Summary Letter Received Date": "August 31, 2022",
    "Submission Date": "July 25, 2023",
    "Regulation Number(s)": [
        "21 CFR 864.7415"
    ],
    "Regulation Name(s)": [
        "Abnormal Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A",
        "Hemoglobin A2",
        "Hemoglobin F",
        "Hemoglobin S",
        "Hemoglobin C",
        "Hemoglobin D-Los Angeles",
        "Hemoglobin E"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "Tube containing K2EDTA"
    ],
    "Instrument(s)/Platform(s)": [
        "Premier Resolution System high performance liquid chromatographic analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Ion-exchange high performance liquid chromatography (HPLC)"
    ],
    "Methodologies": [
        "Separation and quantitation of hemoglobin species"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Reagent",
        "Analytical column",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Trinity Biotech Premier Resolution System for automated ion-exchange HPLC analysis of normal and variant hemoglobins in venous whole blood",
    "Indications for Use Summary": "Automated HPLC system for quantitative analysis of normal hemoglobins (A, A2, F) and qualitative detection of major variants (S, C, D-Los Angeles, E) in venous whole blood from all ages; for professional laboratory use only",
    "fda_folder": "Hematology"
}